Abstract EDMUS is a minimal descriptive record developed for research purposes to docu-
There is a need to standardise morbidity records in patients with multiple sclerosis (MS). The use of a common language is an essential prerequisite in the establishment of a database which will provide descriptive details of the disease and allow rapid identification of appropriate patients for cross-sectional studies or therapeutic trials. The establishment of a database is one of the main themes of the European Concerted Action for Basic Research and Treatment in Multiple Sclerosis organised under the auspices of the Commission of the European Communities (CEC).
The Lyon MS database system, which has been developing since 1976, served as a basis.'
A workshop, Towards a European Database System for Multiple Sclerosis, was held in Lyon, France, [21] [22] September 1990 to complete the design of standardised forms. An EDMUS Steering Committee, composed of members from the various countries of the European Economic Community (EEC), was also nominated. In 1991 the software was refined and tested by the EDMUS Steering Committee members. We present the conceptual and technical design of the EDMUS system, with special emphasis on the Basic Version, which could be considered a minimal descriptive record for any patient with MS. This version is now available and it is anticipated that it will be used in European collaborative studies in MS.
The EDMUS system: basic concepts The aim of this database system is not to replace the clinical notes, as is the case for the North American COSTAR system, but to provide a minimal descriptive record for research purposes. It is user-friendly and fast to facilitate regular and long term use, even in departments with limited facilities. In this respect, a minimal set of obligatory data has been defined. This does not exceed 15 items per patient and takes only a few minutes to complete. Additional complementary data may be entered for a more thorough description.
The description of the clinical manifestations of MS often relies on retrospective data provided by the patient, his relatives or general practitioner. This is usually applicable to the onset of the disease but may also be relevant to the earlier years of the disease. Consequently, in this system, priority has been given to symptoms rather than signs, to include both retrospective and prospective data.
One of the main advantages of computerised data processing is the ability to incorporate algorithms in the programme which allow automatic generation of data. Thus priority has been given to analytical data from which interpretations such as classification of the course, severity and diagnostic confidence of the disease, are computer generated. This procedure has many advantages. It is time saving for the clinician and gives an overview which may be used as a disease summary for any re-examination of the patient. It ensures a standardised way of classifying cases and provides an up-to-date classification of the case. Lastly, it can be made compatible with any future classification, as the data can be analysed using new algorithms.
Flexibility is another essential characteristic of the EDMUS system and both basic and extended versions are available according to the user's needs.
The programme has been developed on the standard database software OMNIS V (Blyth Software During the "no-sequelae period" of the relapsing-remitting phase, a distinction is made between: 1) the relapse at the onset of this period (RO); 2) subsequent relapses with a well identified date of onset and a complete remission (RR);
3) relapses with complete remission but uncertain chronology (RU). The latter option may be necessary for retrospective data.
During the "sequelae period" of the relapsing-remitting phase, a distinction is made between: 1) the relapse at the onset of this period (SO); 2) subsequent relapses with a well identified date of onset and followed by a non-worsening (SN), or a worsening (SW), or a doubtful worsening (S?) ofpre-existing sequelae; 3) relapses with uncertain chronology (SU).
During the chronic progressive phase, a distinction is made between: 1) onset without any initial relapse (POP) and onset with an initial relapse (POR), which are mutually exclusive; 2) subsequent relapses with a well identified chronology (PR); 3) subsequent relapses with uncertain chronology (PU). The possible worsening effect of the relapse during the chronic-progressive phase is not taken into account, as it is often too difficult to assess. Symptoms:
They are distributed in 14 categories, each of them with an appropriate abbreviation: lower extremity dysfunction (LE), upper extremity dysfunction (UE), sensory symptoms (SS), sphincter disturbance (SP), sexual disturbance (SX), facial motor (FM), facial sensory (FS), oculomotor (OM), vestibular andlor cochlear (VE), bulbar (BB), optic neuritis (ON), psychiatric symptoms (PS), mental deterioration (MT) and other symptoms not covered by the preceding categories (OT). Whenever symptoms related to the event to be described are unknown, the code "UK" is ticked.
information during follow up, the original document is completed or, whenever necessary, modified but no extra sheets are used. The minimal set of Obligatory Data is identified by heavy framing. Finally, a "Wait and See" item has been prepared. It is used whenever the diagnosis of MS is doubtful irrespective of assignment in the Poser classification. 2 Section II describes the Current Status (CS) of the patient, that is, the state of the patient at any given date in the disease, and includes: 1) the current disability scores; 2) current immunological treatments, if any; 3) current symptoms and signs; 4) the results of current investigations including electrophysiology, CSF analysis, MRI and other imaging techniques. One CS form should be completed for every date under which the state of the patient is to be described. The CS can be documented retrospectively, whenever it is considered of interest to record clinical or paraclinical data relating to a previous date. It may also be documented prospectively, whenever the patient is seen for follow up. Consequently, section II is made up of additive CS forms, corresponding to the number of assessments collected during the follow up of the patient. In this way it provides a longitudinal description of the disease.
The MS course key-dates form This form is devoted to a successive description of the relapses and the onset of progression, that is, the pivotal events which produce modifications in the symptoms (not signs only) of the disease. As shown in the diagram (fig 1) , two distinct phases are considered. During the relapsing-remitting phase, the relapses are separated by periods of clinical inactivity. A relapse is defined3 as the occurrence of new symptoms, the re-appearance of former ones, or the worsening of current symptoms of at least 24 hours duration. It has a subacute onset; the initial phase is followed by a plateau and, usually, by improvement which may be complete. Transient worsening of symptoms associated with a rise in temperature is not considered as a relapse. Relapses must be separated by at least one month, and symptoms occurring within a month are considered as part of the same episode. Within the relapsing-remitting phase, a no sequelae period and a sequelae period may be considered. During the latter, the sequelae must produce at least a minimum ambulation-related disability or a significant not ambulation-related disability, such as, grade 3 on the EIS-DSS adapted scale (see below). The chronicprogressive phase is defined3 as continuous worsening of symptoms and signs of grade 3 or more on the EIS-DSS adapted scale (see below) for a minimum of six months, whether supervened by relapses or not. According to this scheme, there is a logical sequence in the description of the course. With time, the no sequelae period may be followed in the same patient by sequelae within the relapsing-remitting phase and then by chronic-progressive disease. The automated functions of the EDMUS software Cross-checking of the data The windows which are displayed on the screen are directly derived from the EDMUS chart and, as the data is being entered, the user is automatically guided by the programme. For instance, the unmarried name and the pregnancy boxes will appear on the screen only if a female patient is being registered.
Consistency is maintained within any given window. For example, in the Course KeyDates window, whenever a relapse or the onset of progression is described, its type and date of onset are compared with any preceding events. In the case of inconsistency, a warning message appears and an appropriate correction is requested. A similar control is ensured for the Disability Key-Dates window where dates for the various disability levels must be entered in a logical chronological order.
Overall consistency is also checked automatically. With the exception of the birth date, no date can be entered if it precedes the date of the first relapse in cases with a remittent onset or the date of the onset of progression in cases with a progressive onset which has been registered in the Course Key-Dates window. Similarly, in the Current Status window, it is impossible to enter an EIS-DSS adapted disability level which would be lower than the non-reversible disability level already recorded in the Disability Key-Dates window.
Generation of data At the same time as analytical data are registered, further information is automatically generated and updated as additional information is entered. For instance, the date of the last examination is deduced from the latest date among the Course Key-Dates, the Disability Key-Dates and the Current Status windows. This allows an appropriate calculation of the duration of disease and length of follow up for any case. Similarly, there are algorithms for the classification of the disease course, severity and confidence of diagnosis.
The classification of the disease course is made through the Course Key-Dates window according to established criteria.8The remittent forms show events (relapses) in the exacerbating-remitting phase and none (onset of progression and subsequent relapses, if any) in the chronic-progressive phase, while the remittentprogressive forms show events in both phases, and the progressive forms displays the chronicprogressive phase only. This latter category is subdivided into with and without superimposed relapses.
The classification of the severity of disease is generated from the Disability Key-Dates window according to a previous grade proposal. 8 When severe non-reversible disability has developed (grade . 7 on the EIS-DSS adapted scale), the interval to severe disability is calculated from the date of onset of the disease, that is, the date of the first event in the Course KeyDates window. The following definitions are applied: Hyperacute form: interval to severe non-reversible disability < 5 years. Acute form: interval to severe non-reversible disability = 5-10 years. Subacute form: interval to severe non-reversible disability = 10-15 years. Intermediate form: interval to severe non-reversible disability 2 15 years. Benign form: residual disability less than grade 3 with a disease duration greater than 20 years.
El Pathological verification r Cl Time Dissemination
Not assessable form: case that fails to fulfil the preceding categories.
The generation of the diagnosis classification is more complex. It is displayed on the Diagnosis Synopsis window (fig 2) which has been designed to display items relevant to the generation of the diagnosis using the Poser criteria.2 These items are picked up from the whole case record. In this way, it is very easy to know if a given examination has already been done, what has been its diagnostic value, and the rationale for doing or repeating it. These items are grouped according to the 3 criteria of the Poser classification: 1) dissemination of lesions in time; 2) dissemination of lesions in space, evidence of which may be clinical or paraclinical (evoked potentials, CT scan or MRI examinations); 3) quantitative and/or qualitative abnormalities of immunoglobulins in the cerebrospinal fluid.
The criteria for dissemination in time and the date of completion are generated directly from the second event, if any, which has been entered in the Course Key-Dates window. For dissemination in space, several steps are followed. First, relevant data are extracted from sections I and II of the record. [:E -Wait and See- Figure 2 The "Diagnosis Synopsis" window. This is a window of the EDMUS programme but not a part of the EDMUS form. It displays data which are automatically extracted from the whole case record, such as, Sections I and II of the EDMUS form. From these data, the diagnosis is automatically classified in accordance with the Poser's criteria (see text). SEP = somato-sensory evoked potentials; BAEP = brainstem auditory evoked potentials; MEP = motor evoked potentials; VEP = visual evoked potentials; MRI = magnetic resonance imaging; ND = not done.
for dissemination in space and date at which this was established are completed whenever any of the following combinations from the neuraxis, optic nerve and imaging items is obtained: neuraxis + optic nerve + imaging; neuraxis + optic nerve; neuraxis + imaging; optic nerve + imaging. The CSF criteria are generated as positive as soon as the presence of oligoclonal banding has been entered and/or the IgG index'0 is higher than 070 in a Current Status window. The earliest date of CSF positivity serves as the date of completion of the CSF item.
Finally, the time, space and CSF criteria are automatically combined by the programme to generate and classify the diagnosis in accordance with Poser's guidelines.2 Clinically definite case: "time + space" whatever the "CSF" result. Laboratory-supported definite case: "time + CSF" or "space + CSF". Clinically probable case: "time" only or "space" only. Laboratory-supported case: "CSF" only. Suspected case: case that fails to fulfil the preceding categories.
Case selection and export facilities A selection of the records from the whole file according to any criterion, isolated or in combination, is possible through the Selection window (fig 3) . The list of the selected records may be printed. Data from these records may be transferred to Figure 3 The "Selection" window is a window of the EDMUS programme but not a part of the EDMUS form. It displays the pre-established criteria which may be used, in isolation or in combination, for the selection of records from the whole file. M = male; F = female; yrs = years; incl = inclusive; excl = exclusive; NC = not concerned. Delays and durations are calculated by comparing the date of onset of the disease and the date of onset of the relevant item. For instance, in "delay offirst examination" calculations are made from the date of onset of the disease to the date offirst examination of the patient in the department, data which are present in Section I of the EDMUS form. It is then possible to select records for example, with a minimum (inclusive) of 6 months and a maximum of 1 0 years (exclusive) for the "delay offirst examination" by entering 0O5 and 10 in the appropriate boxes. "Key-words": by entering a given key-word in the appropriate box, it is possible to select records for which such a key-word has been entered in the "Comments" part of Section I of the EDMUS form. 
